Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies

Multiple Sclerosis, Relapsing-Remitting trial results

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Brno, Czechia
  • Research Site Hraddec Kralove, Czechia
  • Research Site Olomouc, Czechia
  • Research Site Pilsen, Czechia
View all 58 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • GSK Investigational Site Sofia, Bulgaria
  • GSK Investigational Site Sofia, Bulgaria
  • GSK Investigational Site Sofia, Bulgaria
  • GSK Investigational Site Calgary, Alberta, Canada
View all 43 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
View all 228 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Brno, Czechia
  • Research Site Olomouc, Czechia
  • Research Site Pilsen, Czechia
  • Research Site Teplice, Czechia
View all 56 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Cefalù, Italy
  • Research Site Gallarate, Italy
  • Research Site Milan, Italy
  • Research Site Padua, Italy